未来肾小球滤过率方程在不同种族肾细胞癌肾切除术患者大队列中的表现
在1443例因肾细胞癌行部分或根治性肾切除术的患者中,评估Palacios等提出的术后未来肾小球滤过率(fGFR)方程的表现,分别用含种族的CKD-EPI 2009方程和不含种族的CKD-EPI 2021方程计算。fGFR方程在总队列中表现良好,但使用CKD-EPI 2021时黑人患者的准确性低于CKD-EPI 2009(76.1% vs 83.4%,P = .003)。
要点
- fGFR方程在总队列中与术后观察eGFR相关性约0.805-0.809,准确性约81.3%-81.7%。
- 黑人患者中,CKD-EPI 2021方程准确性76.1%,低于CKD-EPI 2009的83.4%(P = .003)。
- 多数患者行根治性肾切除术(60.3%),40%为T3-T4期,14.8%有M1疾病。
核心结论
- fGFR方程在大型多种族队列中表现良好,但使用CKD-EPI 2021时准确性相对低于CKD-EPI 2009。
研究设计与样本
- 回顾性分析2005-2021年在本机构数据库因肾细胞癌行部分或根治性肾切除术的患者,纳入术前及术后3-12个月有肌酐值的患者,共1443例。
主要发现
- 总队列中,CKD-EPI 2021方程的相关性/偏倚/准确性/精确度为0.805/-0.5/81.7/7.9-9.0,CKD-EPI 2009为0.809/-0.8/81.3/-8.1至8。
- 中位观察vs预测fGFR:CKD-EPI 2021为58.0 vs 58.7 mL/min/1.73 m2,CKD-EPI 2009为56.0 vs 57.5 mL/min/1.73 m2。
- 黑人患者中,fGFR方程在两种CKD-EPI方程下准确性均>75%,但CKD-EPI 2021准确性低于CKD-EPI 2009(76.1% vs 83.4%,P = .003)。
关键数值与推荐
- fGFR方程:fGFR = 35 + [术前eGFR × 0.65] - 18(若根治性)- [年龄 × 0.25] + 3(若肿瘤>7 cm)- 2(若糖尿病)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the performance of the Palacios et al [Aguilar Palacios D, Wilson B, Ascha M, et al. New baseline renal function after radical or partial nephrectomy: a simple and accurate predictive model. J Urol. 2021;205:1310-1320] post-nephrectomy future glomerular function rate (fGFR) equation in a diverse cohort using both the Chronic Kidney Disease Epidemiology (CKD-EPI) 2009 equation with race, used in the creation of the formula, as well as the CKD-EPI 2021 equation without race. METHODS: Patients who underwent partial or radical nephrectomy for renal cell carcinoma from 2005-2021 were identified in our institutional database. Patients with creatinine values preoperatively and 3-12 months postoperatively were included. Correlation/bias/accuracy/precision of the fGFR equation (fGFR = 35+ [preoperative eGFR × 0.65] - 18 [if radical] - [age × 0.25] + 3 [if tumor >7 cm] - 2 [if diabetes]) with observed postoperative eGFR was determined by both the CKD-EPI-2021 and CKD-EPI 2009 equations. RESULTS: A total of 1443 patients were analyzed. Seventy-one percent (1024) were White and 22.9% (331) were Black. Most underwent radical nephrectomy (60.3%). 40% T3-T4 renal cell carcinoma (RCC), with 14.8% of patients having M1 disease. Median observed vs predicted fGFR was 58.0 vs 58.7 mL/min/1.73 m2 for CKD-EPI 2021 and 56.0 vs 57.5 for CKD-EPI 2009. For the total cohort, the correlation/bias/accuracy/precision of the fGFR equation was 0.805/-0.5/81.7/7.9-9.0 for CKD-EPI 2021 and 0.809/-0.8/81.3/-8.1 to 8 for CKD-EPI 2009. In Black patients, fGFR equation demonstrated >75% accuracy with both CKD-EPI equations; however, accuracy was lower in black patients with the CKD-EPI2021 equation (76.1% vs 83.4%, P = .003). CONCLUSION: The fGFR equation performed well in our large, diverse cohort, though accuracy was relatively lower when using CKD-EPI 2021 compared to CKD-EPI 2009.
引用
- Schmeusser BN, Nicaise EH, Palacios AR, et al. Performance of Future Glomerular Filtration Rate Equation by Race in a Large, Racially Diverse Patient Cohort Undergoing Nephrectomy for Renal Cell Carcinoma. Urology. 2023. PMID: 37852308. doi:10.1016/j.urology.2023.07.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。